Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.


Deloitte Report: Driving Medical Innovation Through Biopharmaceutical Collaboration.

Washington, DC, April 18, 2017 — Emma Van Hook, a director of Policy & Research at the Pharmaceutical Research and Manufacturers of America (PhRMA), reports on The Catalyst that a new report from Deloitte examines the changing landscape of biopharmaceutical research, as stakeholders across the research and development (R&D) ecosystem are increasingly coming together to tackle sciences’ most vexing health challenges.

The new research illustrates there has been a significant shift in recent years from traditional, asset-based or transactional agreements to more open, collaborative approaches for conducting biopharmaceutical research.

Deloitte compiled and analyzed a database of thousands of partnerships initiated between 1995 and 2014. Continue reading